Program 1 – Aid for the Mobility and Improvement of ibs.GRANADA Staff 2025
The Biosanitary Research Institute of Granada launches the Aid for the Mobility and Improvement of the ibs.GRANADA 2025 Staff.
Objective:
The aid for mobility and training of ibs.GRANADA personnel is intended to favor and encourage the mobility of healthcare researchers from the hospital, Nursing and Primary Care fields of ibs.GRANADA, as well as other predoctoral and postdoctoral researchers to carry out stays in research centers that are leaders in research in their field.
The aim is to improve the competitiveness of ibs.GRANADA researchers for their participation in competitive calls for human resources and funding of research projects. It also seeks the establishment of academic links and strategic alliances, or the strengthening of existing ones between the institutions of origin and destination, promoting regular and permanent collaboration between teachers and researchers and between institutions.
Applications aimed at improving knowledge related to healthcare practice will not be considered.
Only those groups that have included the signature of the ibs.GRANADA in the call will be able to participate in the call. at least 70% of the group's publications for the year 2024.
Duration of aid:
The rooms must have a minimum duration of 60 days and maximum of 90 days, and may be enjoyed up to one year after the date of publication of the final granting resolution.
The financial allocation will be up to 70 euros or 100 euros per day of stay in the center depending on whether they are Spanish or foreign centers respectively, which will be paid in a total amount proportional to the number of days granted.
In situations in which the aid is essential, there will be an IRPF withholding of the amount granted.
Deadlines and form of presentation:
The call will be open from the time of publication until March 30, 2025.
The documentation must be submitted by email to the address summon@ibsgranada.es indicating in the subject "MOBILITY GRANTS ibs.GRANADA 2025 .